Ketamine-Assisted Psychedelic Therapy™ Training

This speciality teaches students how to work with both ketamine lozenges and intramuscular injections under medical supervision within a well supported, therapeutic, transpersonal session protocol for clinical and spiritual applications. Each student will have the opportunity to guide twice and journey twice with Ketamine.

This program is comprised of webinars, 3 weekly classes and a 5 day intensive training retreat. Students gain ongoing supervision through an advanced credentialing program.

Course Description

Join the clinical team of the Center for Medicinal Mindfulness for a five day in-person professional training in Ketamine-Assisted Psychedelic Therapy™ (KAPT). Each student will journey twice and guide twice with Ketamine under medical supervision. 

The Center’s training offers:

  • Theoretical understanding of the clinical and psychospiritual applications of KAPT
  • Experiential training in best practices and the practical how-to’s of working skillfully with ketamine in legal settings
  • Practicum for qualifying trainees to participate in ketamine sessions
  • Skill development and practice sessions related to preparation and integration of KAPT sessions
  • Overview of ketamine research and important publications
  • Art-Based Psychedelic Integration experientials
  • Somatic Integration techniques
  • Training in lozenge (oral) & intramuscular (IM) administration, as well as psycholytic and psychedelic models congruent with the Mindfulness-Based Psychedelic Therapy model
  • Q&A and case studies with psychotherapists, interfaith ministers, psychedelic guides and medical professionals from MM’s Clinical Team
  • Integrating Mindfulness-Based Psychedelic Therapy™ with KAPT™

Additional topics covered:

  • Intake, assessment procedures, and contraindications
  • Ethics and professional conduct
  • Safety, consent, accessibility and multicultural considerations
  • Legal landscape and best practices
  • Verbal and non-verbal interventions (including art therapy)
  • Going beyond ketamine for symptom management: symptom resolution, personal growth, and psychospiritual development
  • Transpersonal content and context, transpersonal phenomenon, ancestors, etc.
  • The role of meditation, prayer, ritual and ceremony in KAPT settings
  • KAPT for post-traumatic stress and post-traumatic growth
  • Integrated Protocols utilizing Cannabis-Assisted Psychedelic Therapy (CAPT) with KAPT on different treatment days

Who is this training for?

  • Psychotherapists, ministers and clergy, hospice workers, medical professionals
  • Non-licensed professionals who have completed Psychedelic Guide Training (PSS1 & PSS2)
  • Professionals who have been working in medical-only models with ketamine who want to explore what else is possible
  • Professionals who are interested in learning best practices of Mindfulness-Based Psychedelic Therapy and Ketamine-Assisted Psychedelic Therapy

What is unique about this training?

The Center for Medicinal Mindfulness provides academic, clinical, practical, and experiential training. Qualifying trainees will have the opportunity to participate in ketamine sessions and provide hands-on experience. This training provides you with an opportunity to learn clinical protocols and procedures as well as the opportunity to practice providing ketamine sessions in a clinical and therapeutic setting with medical oversight. Over the course of this in-depth five day training, you will learn directly from the medicine itself, as well as explore the practical knowledge of working with this incredible medicine.



Lead Trainers: Alison McQueen, LPC, ATR-BC, ACS & Dr. Alyse Power

Ketamine-Assisted Psychedelic Therapy Class Code: PSS3-K


  • $4,750 (+$300 Boulder Studio)
  • Scholarship Tuition ($2,850-$3,800)
  • Medical Safety Review may be required if not yet completed, annual requirement

Payment plan – Payment for the standalone class can be split into two or three payments. Extended payment plans with credentialing and electives are also available.


Alison McQueen, LPC, ATR-BC, ACS

Clinical Director and Co-Founder of the Center for Medicinal Mindfulness

Alison McQueen, LPC, ATR-BC, ACS served as a Sub-Investigator and Psychotherapist in the MAPS Phase 2 trials treating PTSD with MDMA-Assisted Psychotherapy, and was trained by the Ketamine Training Center in Ketamine-Assisted Psychotherapy. She practices as a Licensed Professional Counselor and Board Certified Art Therapist, specializing in Mindfulness-Based Psychedelic Therapy, trauma and depth work, and conscious parenting. Alison identifies as a BIPOC and LGBTQI+ ally and is committed to the path of conscious and feminist leadership.

Dr. Alyse Power, MD

Medical Director

Dr. Alyse Power, MD is a Board Certified Family Medicine Physician from Austin, TX and is the Medical Director of the Center for Medicinal Mindfulness, as well as the Owner and Medical Director of Holos Health, where she provides medical cannabis and CBD evaluations. She completed medical school at Texas Tech University Health Sciences Center School of Medicine and Family Medicine Residency in Anchorage, Alaska. Dr. Power has received extensive training in Ketamine-Assisted Psychotherapy with Dr. Philip Wolfson of the prestigious Ketamine Training Center and with Dr. Naveen Thomas of the Center for Medicinal Mindfulness. Alyse is passionate about providing safe, legal and ethical medical oversight for clients experiencing transformational healing through psychedelic therapy.

Guest Presenters from our Clinical Team

Daniel McQueen, MA

Psychedelic Specialist, Educator & Author

Vanessa Cruz

Vanessa Cruz, LPN II, RYT 200, CHWC

Licensed Practical Nurse, End of Life Doula & Psychedelic Guide

Emily Boeschenstein, MA, NLC

Psychedelic Therapist, Art Therapist & Somatic Trauma Specialist

Rev. Kristen Psaki, M.Div

Ordained Minister & Psychedelic Guide

Rev. Jay Waxenberg, MA

Psychedelic Guide, Spiritual Counselor & Ordained Interfaith Minister

Frequently Asked Questions

In the context of mental health and psychotherapy treatments, ketamine is used as an “off-label” treatment for a range of mental conditions and disorders including depression, alcohol and substance dependence, trauma, and several other psychiatric disorders.

Since 1999, the U.S. Drug Enforcement Administration (DEA) has labeled ketamine a Schedule III non-narcotic controlled substance with accepted medical use and safety in the United States under medical supervision. Traditionally ketamine has been used as an anesthetic and analgesic.

The U.S. Food and Drug Administration (FDA) considers ketamine to be an investigational drug and its prescribed use and administration in the mental health context to be “off-label.” Ketamine’s efficacy in treating post-traumatic

stress disorder, major depressive disorder, treatment resistant depression, post-partum depression and other mental health disorders is currently being evaluated in FDA approved clinical trials.

At the Center for Medicinal Mindfulness, we use a sub-anesthetic dose to induce a non-ordinary state of consciousness (NOSC) which leads to significant psychedelic and euphoric effects. In our experience, Ketamine is proving successful in providing symptom relief for depression, traumatic stress, anxiety, and other mental health conditions when administered in conjunction with professional support and guidance.

Ketamine-Assisted Psychedelic Therapy™ (KAPT) is a subspecialty of Mindfulness-Based Psychedelic Therapy that combines the professional oversight of a medical doctor, the emotional support from a trained therapist or guide with the medicinal effects of ketamine. Ketamine serves as a catalyst to bring forward therapeutic content within a non-ordinary state of consciousness while the therapist or guide is present to support clients with preparing for, deepening, and integrating these experiences.

At the Center for Medicinal Mindfulness, we support clients in working with ketamine, not only for symptom management or reduction, but also for addressing the root cause of why these symptoms manifested in the first place. In this setting, meaningful personal growth and transformation is common with this medicine, in addition to basic symptom management. Learn More About Ketamine-Assisted Psychedelic Therapy™ at the Center for Medicinal Mindfulness.

Ketamine-Assisted Psychotherapy (KAP) and Ketamine-Assisted Psychedelic Therapy (KAPT) are not exactly the same thing although there is certainly overlap. KAP is provided by psychotherapists only and frequently occurs in medical-only and clinical-only settings.

KAPT, on the other hand, includes not only psychotherapists, but qualified guides, ministers, nurses, and other practitioners who work directly with licensed medical practitioners. And while the underlying medically supervised treatments remain the same, the palette of therapeutic and transformational treatments offered by KAPT is broader and more diverse. For example, KAPT explores the deep transpersonal and transcendent aspects of the ketamine experience by offering transpersonal and spiritual counseling. And some of the most skillful, ethical, and effective psychedelic guides aren’t necessarily psychotherapists.

The Center for Medicinal Mindfulness brings together the wisdom of modern medicine with sacred and ancient technologies such as mindfulness, ceremony, set & setting, aesthetics, and music.